2013
DOI: 10.1136/jnnp-2012-304728
|View full text |Cite
|
Sign up to set email alerts
|

Titin founder mutation is a common cause of myofibrillar myopathy with early respiratory failure

Abstract: Mutations in TTN are a cause of MFM, and titinopathy is more common than previously thought. The finding of the p.C30071R mutation in 3.9% of our study population is likely due to a British founder effect. The occurrence of novel FN3 domain variants, although still of uncertain pathogenicity, suggests that other mutations in this domain may cause MFM, and that the disease is likely to be globally distributed. We suggest that HMERF due to mutations in the TTN gene be nosologically classified as MFM-titinopathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
111
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 75 publications
(123 citation statements)
references
References 24 publications
9
111
0
Order By: Relevance
“…The Mex6 deletion (c.107889delA, p.Lys35963Asnfs * 9) is present in two unrelated Spanish families [Hackman et al, 2008]; the c.95134T>C, p.Cys31712Arg (first published as p.Cys30071Arg, N2BA-TTN) change has been associated with a founder effect in a series of families of UK origin with myofibrillar myopathy [Pfeffer et al, 2014a]; and the FINmaj mutation, which is the most prevalent TTN mutation, is present in ß2/10,000 in the Finish population due to a founder effect [Udd, 2012]. The vast majority of the known TTN mutations have been identified at the heterozygous state in patients with sporadic or dominant conditions.…”
Section: Population Distribution and Mode Of Inheritancementioning
confidence: 99%
“…The Mex6 deletion (c.107889delA, p.Lys35963Asnfs * 9) is present in two unrelated Spanish families [Hackman et al, 2008]; the c.95134T>C, p.Cys31712Arg (first published as p.Cys30071Arg, N2BA-TTN) change has been associated with a founder effect in a series of families of UK origin with myofibrillar myopathy [Pfeffer et al, 2014a]; and the FINmaj mutation, which is the most prevalent TTN mutation, is present in ß2/10,000 in the Finish population due to a founder effect [Udd, 2012]. The vast majority of the known TTN mutations have been identified at the heterozygous state in patients with sporadic or dominant conditions.…”
Section: Population Distribution and Mode Of Inheritancementioning
confidence: 99%
“…Being of German descent also favors the diagnosis of FLNC-MFM, given that the founder FLNC mutation has been reported in German patients. 3 FLNC sequencing in this patient showed a p.Trp2710X mutation. This p.Trp2710X mutation was first identified as the founder mutation in German patients and later was reported in patients from other ethnic backgrounds.…”
Section: Discussionmentioning
confidence: 99%
“…2,3 TTN-MFM patients usually develop respiratory insufficiency early in the disease course, 3 whereas FLNC-MFM patients experience respiratory compromise later with disease progression. 2 The family history of respiratory compromise developing a decade after the onset of weakness as seen in our patient is typical of FLNC-MFM.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations